Basu Saurav, Maheshwari Vansh, Malik Mansi, Barzangi Kara, Hassan Refaat
Indian Institute of Public Health - Delhi, Public Health Foundation of India, Haryana, India.
University of Cambridge, Trinity Ln, Cambridge, United Kingdom.
PLOS Glob Public Health. 2024 Jul 17;4(7):e0003413. doi: 10.1371/journal.pgph.0003413. eCollection 2024.
We ascertained the burden, determinants, and care cascade in the young and middle-aged patients having co-existing hypertension (HTN), Diabetes Mellitus (DM), and abdominal obesity in India from a secondary data analysis of nationally representative data. The study examined cross-sectional data from the National Family Health Survey (NFHS-5) conducted in India from 2019 to 2021 in 788974 individuals aged 15-49 years including 695707 women and 93267 men. The weighted prevalence of DM-HTN comorbidity with high waist circumference in the sample was 0.75% (95% CI: 0.71 to 0.79) including 46.33% (95% CI: 44.06 to 48.62) newly diagnosed cases detected for HTN and high blood sugars. The weighted prevalence of Metabolic syndrome as per NCEP ATPIII criteria was found to be 1.13% (95% CI: 1.08 to 1.17). Only 46.16% existing cases were treated with both anti-diabetes and antihypertensive medication (full treatment), while 34.71% cases were untreated. On adjusted analysis, increasing age, females, higher wealth index, high fat diet, obesity and comorbidities were significantly associated with having DM-HTN comorbidity along with high-waist circumference. More than half of young and middle aged-population in India with DM-HTN-abdominal obesity triad are not initiated on treatment for DM and HTN comorbidities, while a majority of the previously diagnosed cases have uncontrolled blood pressure and poor glycemic control. The poor cascade of care for DM and HTN in these high-risk group of patients may substantially increase their risk for early progression and severity of microvascular and macrovascular complications especially cardiovascular disease.
我们通过对具有全国代表性的数据进行二次数据分析,确定了印度患有高血压(HTN)、糖尿病(DM)和腹型肥胖的中青年患者的疾病负担、决定因素及治疗流程。该研究分析了2019年至2021年在印度进行的全国家庭健康调查(NFHS - 5)的横断面数据,涉及788974名15 - 49岁的个体,其中包括695707名女性和93267名男性。样本中糖尿病 - 高血压合并高腰围的加权患病率为0.75%(95%置信区间:0.71至0.79),其中46.33%(95%置信区间:44.06至48.62)为新诊断出的高血压和高血糖病例。根据美国国家胆固醇教育计划成人治疗组第三次报告(NCEP ATPIII)标准,代谢综合征的加权患病率为1.13%(95%置信区间:1.08至1.17)。仅有46.16%的现有病例同时接受了抗糖尿病和抗高血压药物治疗(全面治疗),而34.71%的病例未接受治疗。经调整分析,年龄增长、女性、较高的财富指数、高脂肪饮食、肥胖和合并症与糖尿病 - 高血压合并高腰围显著相关。在印度患有糖尿病 - 高血压 - 腹型肥胖三联征的中青年人群中,超过一半未开始接受糖尿病和高血压合并症的治疗,而大多数先前诊断的病例血压未得到控制且血糖控制不佳。这些高危患者群体中糖尿病和高血压治疗流程不佳,可能会大幅增加他们发生微血管和大血管并发症尤其是心血管疾病早期进展和严重程度的风险。